Coming soon: The EURas consortium grant agreement has now been signed, new recruitment will open soon
The European network for neurodevelopmental Rasopathies, consisting of 16 partners across Europe, is about to formally begin.
Our laboratory will be recruiting one researcher at postdoc or graduate student levels to identify robust phenotypic differences in neurons differentaited from human iPS cells representing each of 3 rare diseases – SynGAP, Cardio-Facio-Cutaneous syndrome and Costello Syndrome, These differences will be used develop a simple minaturised assay, which will be applied to a repurposing library to screen, identify and validate hits that could potentially see a rapid entry into clinical use.
A formal opening for a position will be posted soon.
Last updated on March 5, 2025
Recent Posts
- Meet our SAB over lunch!Turku Bioscience and BioCity Turku Scientific Advisory Board (SAB) is visiting Turku next week, and Read moreSeptember 16, 2026
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026